Use of Talimogene Laherparepvec to Treat Cutaneous Squamous Cell Carcinoma in a Renal Transplant Patient by Max Miller, Nancy H Kim, Maya K Thosani, Justin C Moser

Get full text

618 Phase 1 clinical trial evaluating the safety, biologic and anti-tumor activity of the novel STING agonist IMSA101 administered both as monotherapy and in combination with PD-(L... by Syed Kazmi, Lijun Sun, Angela Alistar, Ezra Cohen, Timothy Yap, Devalingam Mahalingam, Justin C Moser, Edward Garmey, Teresa Mooneyham

Real‐world survival of patients with advanced BRAF V600 mutated melanoma treated with front‐line BRAF/MEK inhibitors, anti‐PD‐1 antibodies, or nivolumab/ipilimumab by Justin C. Moser, Danli Chen, Siwen Hu‐Lieskovan, Kenneth F. Grossmann, Shiven Patel, Sarah V. Colonna, Jian Ying, John R. Hyngstrom

Get full text

Development and external validation of a prognostic nomogram for metastatic uveal melanoma. by Sara Valpione, Justin C Moser, Raffaele Parrozzani, Marco Bazzi, Aaron S Mansfield, Simone Mocellin, Jacopo Pigozzo, Edoardo Midena, Svetomir N Markovic, Camillo Aliberti, Luca G Campana, Vanna Chiarion-Sileni

Get full text

692 COMMANDER-001: safety data from a phase I/II dose escalation/expansion study of SQZ-eAPC-HPV, a cell-based mRNA therapeutic cancer vaccine for HPV16+ solid tumors by Antonio Jimeno, Michael S Gordon, Howard Bernstein, Scott Loughhead, Jong Chul Park, Justin C Moser, Wade T Iams, Meredith Pelster, Kerry J Rodabaugh, Julia Jennings, Nathan Miselis, Marshelle S Warren, Victoria Villaflor, Melinda Morrison

737 A phase 1/1b study of the tumor-activated IL-2 prodrug WTX-124 alone or in combination with pembrolizumab in patients with immunotherapy-sensitive locally advanced or metastati... by Brendan Curti, Igor Puzanov, Mateusz Opyrchal, Christopher J Nirschl, Mehmet A Bilen, Kristin Morris, Justin C Moser, Ildefonso Rodriguez Rivera, Saero Park, Marissa Bruno, Paul Windt, Kulandayan K Subramanian, Sameer S Chopra, Randi Isaacs

736 A phase 1/2 open-label, dose-escalation study of ST-067, a decoy-resistant IL-18 cytokine, given as a monotherapy and with pembrolizumab in advanced solid tumor malignancies by Mario Sznol, Harriet Kluger, Igor Puzanov, Gerald S Falchook, Ryan Sullivan, Matthew H Taylor, Justin C Moser, Aaron M Ring, Virginia E Paton, David Chonzi, Brage Garofalo, Mark Sonnemann, Hirdesh Uppal, Jeremy Barton, Beatrice Y McQueen

Multi-omic profiling reveals discrepant immunogenic properties and a unique tumor microenvironment among melanoma brain metastases by Gino K. In, Jennifer R. Ribeiro, Jun Yin, Joanne Xiu, Matias A. Bustos, Fumito Ito, Frances Chow, Gabriel Zada, Lindsay Hwang, April K. S. Salama, Soo J. Park, Justin C. Moser, Sourat Darabi, Evidio Domingo-Musibay, Maria L. Ascierto, Kim Margolin, Jose Lutzky, Geoffrey T. Gibney, Michael B. Atkins, Benjamin Izar, Dave S. B. Hoon, Ari M. VanderWalde

Get full text